EP1603535A4 - Diagnostic et traitement faisant appel a un inhibiteur de l'aromatase - Google Patents

Diagnostic et traitement faisant appel a un inhibiteur de l'aromatase

Info

Publication number
EP1603535A4
EP1603535A4 EP04757537A EP04757537A EP1603535A4 EP 1603535 A4 EP1603535 A4 EP 1603535A4 EP 04757537 A EP04757537 A EP 04757537A EP 04757537 A EP04757537 A EP 04757537A EP 1603535 A4 EP1603535 A4 EP 1603535A4
Authority
EP
European Patent Office
Prior art keywords
diagnosis
treatment
aromatase inhibitor
aromatase
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04757537A
Other languages
German (de)
English (en)
Other versions
EP1603535A2 (fr
Inventor
Michel Gensini
Tony Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethicon Inc
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of EP1603535A2 publication Critical patent/EP1603535A2/fr
Publication of EP1603535A4 publication Critical patent/EP1603535A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP04757537A 2003-03-18 2004-03-17 Diagnostic et traitement faisant appel a un inhibiteur de l'aromatase Withdrawn EP1603535A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45551003P 2003-03-18 2003-03-18
US455510P 2003-03-18
PCT/US2004/008082 WO2004082626A2 (fr) 2003-03-18 2004-03-17 Diagnostic et traitement faisant appel a un inhibiteur de l'aromatase

Publications (2)

Publication Number Publication Date
EP1603535A2 EP1603535A2 (fr) 2005-12-14
EP1603535A4 true EP1603535A4 (fr) 2008-10-15

Family

ID=33030013

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04757537A Withdrawn EP1603535A4 (fr) 2003-03-18 2004-03-17 Diagnostic et traitement faisant appel a un inhibiteur de l'aromatase

Country Status (2)

Country Link
EP (1) EP1603535A4 (fr)
WO (1) WO2004082626A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006087722A1 (fr) * 2005-02-17 2006-08-24 Hadasit Medical Research Services And Development Ltd. Bisphosphonates pour le traitement de l'endometriose
WO2011006510A1 (fr) 2009-07-17 2011-01-20 Technical University Of Denmark Technique de chargement pour préparer des liposomes contenant des radionucléide et ionophores et dans lesquels l'ionophore est la 2-hydroxyquionoléine (carbostyrile) ou des 2-hydroxyquinoléines structurellement reliées
JP5947807B2 (ja) 2010-12-14 2016-07-06 テクニカル ユニバーシティ オブ デンマークＴｅｃｈｎｉｃａｌ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｄｅｎｍａｒｋ ナノ粒子組成物への放射性核種の封入
RU2481587C1 (ru) * 2012-02-21 2013-05-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт акушерства и гинекологии им. Д.О. Отта" Северо-Западного отделения Российской академии медицинских наук Способ оценки ароматазной активности
CN102920658B (zh) * 2012-11-02 2015-01-21 艾韦特(溧阳)医药科技有限公司 与glp-1类似物和聚乙二醇结合的脂质体及其制备方法
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
US10556916B2 (en) 2014-04-01 2020-02-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000062813A2 (fr) * 1999-04-20 2000-10-26 The University Of British Columbia Lipides peg cationiques et méthodes d'utilisation
WO2001020990A1 (fr) * 1999-09-23 2001-03-29 Bioresponse L.L.C. Produits phytochimiques destines au traitement de mastalgie et d'endometriose
WO2001093836A2 (fr) * 2000-06-09 2001-12-13 Teni Boulikas Encapsulation d'adn plasmidique (lipogenesmc) et d'agents therapeutiques contenant des conjugues peptidiques a signal de localisation nucleaire/fusogenes dans des complexes cibles de liposomes
US20020177574A1 (en) * 2001-04-20 2002-11-28 Taylor Hugh S. Endometrial gene therapy
WO2002096927A2 (fr) * 2001-05-29 2002-12-05 Ribozyme Pharmaceuticals, Incorporated Modulation a base de l'acide nucleique des maladies et troubles de l'appareil reproducteur chez la femme

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527528A (en) * 1989-10-20 1996-06-18 Sequus Pharmaceuticals, Inc. Solid-tumor treatment method
JP2700595B2 (ja) * 1992-05-21 1998-01-21 呉羽化学工業株式会社 アゾール誘導体を含有する抗アロマターゼ剤
US6056973A (en) * 1996-10-11 2000-05-02 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method of preparation
AU4056000A (en) * 1999-04-02 2000-10-23 Center For Molecular Medicine And Immunology Method of detecting endometriosis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000062813A2 (fr) * 1999-04-20 2000-10-26 The University Of British Columbia Lipides peg cationiques et méthodes d'utilisation
WO2001020990A1 (fr) * 1999-09-23 2001-03-29 Bioresponse L.L.C. Produits phytochimiques destines au traitement de mastalgie et d'endometriose
WO2001093836A2 (fr) * 2000-06-09 2001-12-13 Teni Boulikas Encapsulation d'adn plasmidique (lipogenesmc) et d'agents therapeutiques contenant des conjugues peptidiques a signal de localisation nucleaire/fusogenes dans des complexes cibles de liposomes
US20020177574A1 (en) * 2001-04-20 2002-11-28 Taylor Hugh S. Endometrial gene therapy
WO2002096927A2 (fr) * 2001-05-29 2002-12-05 Ribozyme Pharmaceuticals, Incorporated Modulation a base de l'acide nucleique des maladies et troubles de l'appareil reproducteur chez la femme

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TAKAYAMA KAZUTO ET AL: "Treatment of severe postmenopausal endometriosis with an aromatase inhibitor", FERTILITY AND STERILITY, ELSEVIER SCIENCE INC, NEW YORK, NY, US, vol. 69, no. 4, 1 April 1998 (1998-04-01), pages 709 - 713, XP002379276, ISSN: 0015-0282 *

Also Published As

Publication number Publication date
WO2004082626A3 (fr) 2004-11-11
EP1603535A2 (fr) 2005-12-14
WO2004082626A2 (fr) 2004-09-30

Similar Documents

Publication Publication Date Title
EP1538965A4 (fr) Endoscope et dispositif de traitement auxiliaire integre
EP1599164A4 (fr) Procedes de traitement, de prevention et de diagnostic d'infections a helicobacter
EP1551285A4 (fr) Fluorescence et reflectance permettant un diagnostic ameliore
NO20034855D0 (no) Behandling og diagnose av makrofagmediert sykdom
EP1589933A4 (fr) Compositions et methodes pour le diagnostic et le traitement d'une tumeur
EP1553912A4 (fr) Compositions et methodes pour le diagnostic et pour le traitement d'une tumeur
EP1643986A4 (fr) Inhibiteurs de la beta-secretase de phenylcarboxylate destines au traitement de la maladie d'alzheimer
EP1572741A4 (fr) Agents diagnostiques et therapeutiques
EP1656359A4 (fr) Inhibiteurs macrocycliques de la beta-secretase destines au traitement de la maladie d'alzheimer
EP1539251A4 (fr) Compositions et methodes permettant le diagnostic et le traitement d'etats pathologiques impliquant l'angiogenese
EP1485109A4 (fr) Traitement vasculaire
EP1889058A4 (fr) Diagnostic et traitement de l'endométriose
EP1603535A4 (fr) Diagnostic et traitement faisant appel a un inhibiteur de l'aromatase
EP1817050A4 (fr) Diagnostic et traitement de la maladie d'alzheimer
EP1512405A4 (fr) Composition de traitement de chloasma et composition de traitement de matite
EP1756166A4 (fr) Diagnostic et traitement du cancer de la prostate
NO20053776D0 (no) Diagnostic imaging agents with MMP inhibitory activity
EP1781685A4 (fr) Agents therapeutiques et diagnostiques
EP1606418A4 (fr) Methodes de diagnostic et de traitement de l'epilepsie
EP1781826A4 (fr) Compositions et techniques de diagnostic et de traitement d'orthopoxvirus
EP1573440A4 (fr) Procedes de diagnostic de l'acathisie
EP1794187A4 (fr) Procédés de diagnostic et de traitement d"une infection par m. tuberculosis et réactifs correspondants
EP1766079A4 (fr) Diagnostic et prévision de l'évolution du cancer du sein
IL153183A0 (en) Agents for imaging and diagnostic methods using them
DE60323153D1 (de) Diagnosesequenzen für maul- und klauenseuche

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050817

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
RBV Designated contracting states (corrected)

Designated state(s): DE ES FR GB IT

A4 Supplementary search report drawn up and despatched

Effective date: 20080911

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 15/00 20060101ALI20080905BHEP

Ipc: A61K 51/12 20060101ALI20080905BHEP

Ipc: A61K 9/127 20060101AFI20051027BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090421